FDA Inspection 1168919 — Omega & Delta Co., Inc.

Omega & Delta Co., Inc. — FEI 2650091

The FDA completed an inspection of Omega & Delta Co., Inc. on May 6, 2022 in Carolina, PR. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 10 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
May 6, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Carolina, PR (United States)

Citations

IDCFRDescription
111121 CFR 211.25(a)Training , Education , Experience overall
117721 CFR 211.63Equipment Design, Size and Location
122721 CFR 211.67(c)Cleaning/maintenance records not kept
135821 CFR 211.100(b)SOPs not followed / documented
145021 CFR 211.113(a)Procedures for non-sterile drug products
183321 CFR 211.84(d)(1)Identity Testing of Each Component
191221 CFR 211.166(a)Written program not followed
202721 CFR 211.192Investigations of discrepancies, failures
355921 CFR 211.56(a)Sanitation--buildings not clean, free of infestation
900121 CFR 211.22(a)Lack of quality control unit